Involvement of NMDA and AMPA receptors in The antidepressant-like activity of antidepressant drugs in The forced swim test

Pharmacological Reports

Volumn 65, Issue 4, 2013, Pages 991-997

  Wolak, Malgorzata ^a   Siwek, Agata ^a   Szewczyk, Bernadeta ^b   Poleszak, Ewa ^c   Pilc, Andrzej ^a,b   Popik, Piotr ^a   Nowak, Gabriel ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Ampa; Antidepressants; Forced swim test; Ligands; Mice; Nmda

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; AMPA RECEPTOR AGONIST; CX 614; ESCITALOPRAM; IMIPRAMINE; MILNACIPRAN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REBOXETINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; FORCED SWIMMING TEST; IMMOBILIZATION STRESS; LOCOMOTION; MONOTHERAPY; MOUSE; NONHUMAN;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; ANTIDEPRESSIVE AGENTS; CITALOPRAM; CYCLOPROPANES; IMIPRAMINE; IMMOBILITY RESPONSE, TONIC; MALE; MICE; MORPHOLINES; MOTOR ACTIVITY; N-METHYLASPARTATE; OXAZINES; QUINOXALINES; RECEPTORS, AMPA; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84886501832     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71080-6     Document Type: Article

References (22)

1. Ampuero E, Rubio FJ, Falcon R, Sandoval M, Diaz-Veliz G, Gonzalez RE, Earle N et al.: Chronic fluoxetine treatment induces structural plasticity and selective changes in glutamate receptor subunits in The rat cerebral cortex. Neuroscience, 2010, 169, 98-108.
2. Barbon A, Caracciolo L, Orlandi C, Musazzi L, Mallei A, La Via L, Bonini D et al.: Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels. Neurochem Int, 2011, 59, 896-905.
3. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry, 2000, 47, 351-354.
4. Bleakman D, Alt A, Witkin JM: AMPA receptors in The Therapeutic management of depression. CNS Neurol Disord Drug Targets, 2007, 6, 117-126.
5. Dybala M, Siwek A, Poleszak E, Pilc A, Nowak G: Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in The forced swim test. J Neural Transm, 2008, 115, 1519-1520.
6. Kaster MP, Machado DG, Santos ARS, Rodrigues ALS: Involvement of NMDA receptors in The antidepressantlike action of adenosine. Pharmacol Rep, 2012, 64, 706-713.
7. Li X, Witkin JM, Need AB, Skolnick P: Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell Mol Neurobiol, 2003, 23, 419-430.
8. Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK: Cellular mechanisms underlying The antidepressant effects of ketamine: role of a-Amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry, 2008, 63, 349-352.
9. Nations KR, Dogterom P, Bursi R, Schipper J, Greenwald S, Zraket D, Gertsik L et al.: Examination of Org 26576, an AMPAreceptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial. J Psychopharmacol, 2012, 26, 1525-1539.
10. Paul IA, Nowak G, Layer RT, Popik P, Skolnick P: Adaptation of The NMDA receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther, 1994, 269, 95-102.
11. Poleszak E, Wróbel A, Szewczyk B, Socala K, Kasperek R, Blicharska E, Nowak G, Wlay P: Involvement of NMDA receptor complex in The anxiolytic-like effects of chlodiazepoxide in mice. J Neural Transm, 2011, 118, 857-864.
12. Porsolt RD, Bertin A, Jalfre M: Behavioural despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn, 1977, 229, 327-336.
13. Skolnick P, Popik P, Trullas R: Glutamate-based antidepressants: 20 years on. Trends Pharmacol Sci, 2009, 30, 563-569.
14. Szegedi V, Juhász G, Zhang X, Barkóczi B, Qi H, Madeira A, Kapus G et al.: Tianeptine potentiates AMPA receptors by activating CaMKII and PKA via The p38, p42/44 MAPK and JNK pathways. Neurochem Int, 2011, 59, 1109-1122.
15. Szewczyk B, Palucha-Poniewiera A, Poleszak E, Pilc A, Nowak G: Authors' response: The differences in AMPA receptor dependence on antidepressant-like activity. Expert Opin Investig Drugs, 2012, 21, 584-585.
16. Szewczyk B, Palucha-Poniewiera A, Poleszak E, Pilc A, Nowak G: Investigational NMDA receptor modulators for depression. Expert Opin Investig Drugs, 2012, 21, 91-102.
17. Szewczyk B, Poleszak E, Sowa-Kuema M, Wróbel A, Slotwiñski S, Listos J, Wla Y P et al.: Involvement of NMDA and AMPA receptors in The antidepressant-like activity of zinc in The forced swim test. Amino Acids, 2010, 39, 205-217.
18. Witkin JM, Li X: New approaches to The pharmacological management of major depressive disorder. Adv Pharmacol, 2009, 57, 347-379.
19. Wla Y P, Kasperek R, Wla Y A, Szumilo M, Woyniak M, Wróbel A, Nowak G, Poleszak E: The NMDA and AMPA receptors are involved in The antidepressant-like activity of tianeptine in The forced swim test. Pharmacol Rep, 2011, 63, 1526-1532.
20. Wolosker H: NMDA receptor regulation by D-serine: new findings and perspectives. Mol Neurobiol, 2007, 36, 152-164.
21. Wong DT, Threlkeld PG, Best KL, Bymaster FP: A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain. J Pharmacol Exp Ther, 1982, 222, 61-65.
22. Yang C, Zhou W, Li X, Yang J: A bright future of researching AMPA receptor agonists for depression treatment. Expert Opin Investig Drugs, 2012, 21, 583-584